We are live on
!
Find out more
Point72 Asset Management Portfolio holdings
AUM
$78.1B
1-Year Est. Return
55.25%
This Fund
S&P 500
This Quarter
Est. Return
+12.87%
1 Year Est. Return
+55.25%
3 Year Est. Return
+151.79%
5 Year Est. Return
+188.05%
10 Year Est. Return
+800.63%
AUM
$41.3B
AUM Growth
-$94.8M
(-0.23%)
Cap. Flow
-$3.99B
Cap. Flow
% of AUM
-9.68%
Top 10 Holdings %
Top 10 Hldgs %
13.8%
Holding
2,749
New
670
Increased
633
Reduced
621
Closed
636
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$583M |
| 2 |
Fox Class A
FOXA
|
+$276M |
| 3 |
AT&T
T
|
+$261M |
| 4 |
PayPal
PYPL
|
+$258M |
| 5 |
Edwards Lifesciences
EW
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dell
DELL
|
+$365M |
| 2 |
Meta Platforms (Facebook)
META
|
+$348M |
| 3 |
Union Pacific
UNP
|
+$291M |
| 4 |
Johnson Controls International
JCI
|
+$225M |
| 5 |
Honeywell
HON
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.31% |
| 2 | Healthcare | 13.89% |
| 3 | Consumer Discretionary | 10.27% |
| 4 | Industrials | 9.75% |
| 5 | Energy | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Quest Diagnostics
DGX
$26B
| $12.4M | 0.03% |
93,100
-49,269
| -35% | -$6.39M |
|
627
Darling Ingredients
DAR
$9.36B
| $12.4M | 0.03% |
266,288
+190,988
| +254% | +$8.41M |
|
628
Macerich
MAC
$7.29B
| $12.3M | 0.03% |
712,979
+186,454
| +35% | +$3.04M |
|
629
Maravai LifeSciences
MRVI
$938M
| $12.2M | 0.03% |
1,410,362
+459,162
| +48% | +$3.11M |
|
630
Wave Life Sciences
WVE
$1.16B
| $12.2M | 0.03% |
1,974,737
-1,238,763
| -39% | -$6.2M |
|
631
Portillo's
PTLO
$333M
| $12.2M | 0.03% |
857,780
+319,146
| +59% | +$4.43M |
|
632
Corteva
CTVA
$53.7B
| $12.1M | 0.03% |
209,551
-1,192,057
| -85% | -$61.6M |
|
633
CALL
Goldman Sachs
GS
$316B
| $12M | 0.03% |
28,800
-37,600
| -57% | -$14.6M |
|
|
ITCI
634
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $12M | 0.03% |
+173,766
| New | +$11.9M |
|
|
SAGE
635
DELISTED
Sage Therapeutics
SAGE
| $12M | 0.03% |
+641,211
| New | +$14.8M |
|
636
HealthEquity
HQY
$8.65B
| $12M | 0.03% |
146,754
-330,624
| -69% | -$25.8M |
|
637
CALL
Newmont
NEM
$110B
| $11.9M | 0.03% |
+332,400
| New | +$11.5M |
|
638
Xenon Pharmaceuticals
XENE
$6.21B
| $11.9M | 0.03% |
275,859
-599,206
| -68% | -$27.6M |
|
|
CDMO
639
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $11.8M | 0.03% |
1,768,317
+1,258,486
| +247% | +$8.66M |
|
640
Perrigo
PRGO
$1.88B
| $11.8M | 0.03% |
367,900
-23,000
| -6% | -$725K |
|
|
JBIO
641
Jade Biosciences
JBIO
$1.3B
| $11.8M | 0.03% |
11,424
-1,190
| -9% | -$909K |
|
642
Ventas
VTR
$47.3B
| $11.8M | 0.03% |
271,400
-29,145
| -10% | -$1.32M |
|
643
CALL
Simon Property Group
SPG
$73.1B
| $11.8M | 0.03% |
75,100
-2,900
| -4% | -$425K |
|
|
EXAS
644
CALL
DELISTED
Exact Sciences
EXAS
| $11.7M | 0.03% |
170,000
+130,000
| +325% | +$8.22M |
|
645
Chemours
CC
$2.22B
| $11.7M | 0.03% |
446,092
+131,792
| +42% | +$3.75M |
|
646
Fate Therapeutics
FATE
$309M
| $11.6M | 0.03% |
1,584,300
-1,904,863
| -55% | -$11.8M |
|
647
PUT
Rivian
RIVN
$22.4B
| $11.6M | 0.03% |
1,061,300
+812,400
| +326% | +$11.7M |
|
648
Expro Ltd
XPRO
$1.83B
| $11.6M | 0.03% |
581,024
+313,600
| +117% | +$5.63M |
|
649
PUT
Wingstop
WING
$3.36B
| $11.6M | 0.03% |
31,600
+20,300
| +180% | +$6.32M |
|
650
ACV Auctions
ACVA
$1.35B
| $11.5M | 0.03% |
615,088
-403,392
| -40% | -$6.32M |
|
Similar funds
CBU
BC
Point72 Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Point72 Asset Management held 2,749 positions worth $41.3B, down 0.23% from $41.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Point72 Asset Management withdrew a net $3.99B in Q1 2024, closing 636 positions and reducing 621 holdings. Its most notable exit was Union Pacific, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Point72 Asset Management opened a new position in Broadcom worth $623M.
- Point72 Asset Management's largest Q1 2024 buy was Broadcom: 4,703,650 shares worth $623M.
- Point72 Asset Management added most to Fox Class A in Q1 2024, an estimated $276M increase.
- Point72 Asset Management's biggest Q1 2024 reduction was Dell, cutting an estimated $365M.
- Point72 Asset Management fully exited Union Pacific in Q1 2024, selling an estimated $291M.
- Point72 Asset Management's ten largest holdings make up 14% of its $41.3B portfolio in Q1 2024.
- Point72 Asset Management opened 670 new positions and closed 636 in Q1 2024.
- Point72 Asset Management's portfolio value fell 0.23% quarter-over-quarter to $41.3B.
Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.